ArticleJournal of translational medicine2026

CABIT: a novel biomarkers-integrated inflammatory risk tool for ischemic heart disease developed in the USA and prospectively validated in China.

Wenhui Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.